Compare Indo Euro Indch. with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.05
- The company has been able to generate a Return on Equity (avg) of 4.19% signifying low profitability per unit of shareholders funds
Flat results in Dec 25
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 8 Cr (Micro Cap)
43.00
21
0.00%
-0.01
1.46%
0.69
Total Returns (Price + Dividend) 
Indo Euro Indch. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Indo Euro Indchem Ltd Falls to 52-Week Low of Rs.8.01 Amidst Weak Financial Metrics
Indo Euro Indchem Ltd, a micro-cap player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.8.01 today, marking a significant decline amid broader market weakness and sector underperformance.
Read full news article
Indo Euro Indchem Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Technical Setbacks
Indo Euro Indchem Ltd, a player in the specialty chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 10 March 2026. This shift reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid ongoing operational challenges.
Read full news article Announcements 
Revised Financial Result For The Quarter Ended September 30 2025
02-Mar-2026 | Source : BSERevised Financial Results for the 2nd quarter and half year ended September 30 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Feb-2026 | Source : BSENewspaper Advertisement
Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting
11-Feb-2026 | Source : BSEBoard Meeting Outcome for considered and approval unaudited financial results of the company along with Auditors Limited Review Report for the 3rd quarter ended December 31 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Vardhman Chhaganlal Shah (26.57%)
Abhay Shrawan Nikam (1.84%)
41.56%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is -70.21% vs 318.81% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -95.24% vs 2,000.00% in Dec 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -25.51% vs 143.33% in Sep 2024
Growth in half year ended Sep 2025 is 4.35% vs 2,200.00% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -44.29% vs 195.31% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -43.18% vs 2,100.00% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 28.37% vs 7.34% in Mar 2024
YoY Growth in year ended Mar 2025 is 800.00% vs -81.82% in Mar 2024







